Nov 23, 2011
1:40
For every 40 shares held, investors received 1. The price per share adjusted from $0.15 to $0.00.
The split itself did not change the total investment value.
Poniard Pharmaceuticals, Inc. (PARD) trades on the Other OTC in the Biotechnology industry.
Poniard Pharmaceuticals, Inc. company overviewThe latest split shown was on November 23, 2011. It was a 1-for-40 reverse split, so shareholders received 1 share for every 40 they held.
This history records 3 reverse splits between December 14, 1993 and November 23, 2011.